| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |